ATE294864T1 - Äusseres membranprotein von haemophilus - Google Patents

Äusseres membranprotein von haemophilus

Info

Publication number
ATE294864T1
ATE294864T1 AT94900671T AT94900671T ATE294864T1 AT E294864 T1 ATE294864 T1 AT E294864T1 AT 94900671 T AT94900671 T AT 94900671T AT 94900671 T AT94900671 T AT 94900671T AT E294864 T1 ATE294864 T1 AT E294864T1
Authority
AT
Austria
Prior art keywords
haemophilus
nucleic acid
membrane protein
outer membrane
diagnosis
Prior art date
Application number
AT94900671T
Other languages
English (en)
Inventor
Pele Chong
Wayne Thomas
Yan-Ping Yang
Sheena Loosmore
Dwo Yuan Charles Sia
Michel Klein
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of ATE294864T1 publication Critical patent/ATE294864T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1242—Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94900671T 1992-11-23 1993-11-23 Äusseres membranprotein von haemophilus ATE294864T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224584A GB9224584D0 (en) 1992-11-23 1992-11-23 Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
PCT/CA1993/000501 WO1994012641A1 (en) 1992-11-23 1993-11-23 Haemophilus outer membrane protein

Publications (1)

Publication Number Publication Date
ATE294864T1 true ATE294864T1 (de) 2005-05-15

Family

ID=10725587

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900671T ATE294864T1 (de) 1992-11-23 1993-11-23 Äusseres membranprotein von haemophilus

Country Status (11)

Country Link
US (3) US6013514A (de)
EP (1) EP0668916B1 (de)
JP (1) JP2907552B2 (de)
AT (1) ATE294864T1 (de)
AU (1) AU683435B2 (de)
BR (1) BR9307510A (de)
CA (1) CA2149319C (de)
DE (1) DE69333802T8 (de)
GB (1) GB9224584D0 (de)
RU (1) RU2141528C1 (de)
WO (1) WO1994012641A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205704D0 (en) 1992-03-16 1992-04-29 Connaught Lab High molecular weight membrane proteins of non-typeable haemophilus
CN1267553C (zh) * 1993-11-08 2006-08-02 康诺特实验室有限公司 嗜血杆菌属转铁蛋白受体基因
US6361779B1 (en) 1993-11-08 2002-03-26 Aventis Pasteur Limited Transferrin receptor genes
US5981503A (en) * 1994-06-07 1999-11-09 Connaught Laboratories Limited Analog of Haemophilus Hin47 with reduced protease activity
US5939297A (en) * 1994-07-21 1999-08-17 Connaught Laboratories Limited Analog of haemophilus HIN47 with reduced protease activity
US5506139A (en) * 1994-07-21 1996-04-09 Connaught Laboratories Limited Analog of haemophilus Hin47 with reduced protease activity
US6147057A (en) * 1994-07-21 2000-11-14 Connaught Laboratories Limited Analog of Haemophilus Hin47 with reduced protease activity
DE69533102T2 (de) * 1994-07-21 2005-06-02 Aventis Pasteur Ltd., Toronto Analog von haemophilus hin47 mit verminderter protease aktivität
RU2196176C2 (ru) * 1994-07-21 2003-01-10 Коннот Лабораториз Лимитед АНАЛОГ HIN47 Haemophilus С РЕДУЦИРОВАННОЙ ПРОТЕАЗНОЙ АКТИВНОСТЬЮ
US5681570A (en) 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
WO1996032963A1 (en) * 1995-04-17 1996-10-24 Henry M. Jackson Foundation For The Advancement Of Military Medicine Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
US6355450B1 (en) 1995-04-21 2002-03-12 Human Genome Sciences, Inc. Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
US5780606A (en) * 1995-06-07 1998-07-14 Connaught Laboratories Limited Neisseria meningitidis capsular polysaccharide conjugates
GB9513074D0 (en) 1995-06-27 1995-08-30 Cortecs Ltd Novel anigen
US6033877A (en) * 1995-11-02 2000-03-07 Research Foundation Of State University Of New York Peptide expression and delivery system
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein
US6211159B1 (en) 1997-04-11 2001-04-03 University Of Toronto Flagellin gene, FlaC of campylobacter
US5977337A (en) * 1997-06-03 1999-11-02 Connaught Laboratories Limited Lactoferrin receptor genes of Moraxella
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
KR20070089890A (ko) * 1998-06-03 2007-09-03 글락소스미스클라인 바이오로지칼즈 에스.에이. 모락셀라 카탈리스로부터의 ｂａｓｂ027 단백질 및 유전자,항원, 항체, 및 이들의 용도
US9134303B1 (en) 1998-08-25 2015-09-15 Alere Scarborough, Inc. ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto
US6824997B1 (en) 1998-09-18 2004-11-30 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US6610306B2 (en) 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
US7241449B1 (en) 1999-04-12 2007-07-10 Aventis Pasteur Limited Transferrin receptor genes of moraxella
EP1246848A1 (de) * 1999-12-27 2002-10-09 University Of Manitoba Genetische impfstoffe zur herstellung von antikörpern aus dem eigelb von hühnern gegen enterotoxigenes escherichia coli und sonstige pathogenen
JP4856836B2 (ja) * 2000-03-01 2012-01-18 バイナックス インコーポレイティッド 標的細菌またはその標的糖質抗原成分の存在を検出する方法
US7192725B2 (en) 2000-05-19 2007-03-20 University Of Toronto Flagellin gene, flaC of Campylobacter
GB0022017D0 (en) * 2000-09-08 2000-10-25 Univ Dundee Cell assays
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
CA2493124C (en) 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
BRPI0620460B8 (pt) 2005-12-22 2021-05-25 Glaxosmithkline Biologicals Sa uso de composição imunogênica para bebês, e, processo para produzir uma vacina
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
EP1973933B1 (de) 2006-01-17 2020-06-24 Forsgren, Arne Neues oberflächenexponiertes haemophilus influenzae-protein (protein e; pe)
PL2114421T3 (pl) * 2007-03-05 2018-07-31 Om Pharma Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania
BRPI0813644B8 (pt) 2007-06-26 2021-05-25 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
EP2544714A1 (de) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Impfstoffzusammensetzung
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
GB2600654B (en) 2017-05-30 2022-11-02 Glaxosmithkline Biologicals Sa Novel devices
WO2019106192A1 (en) 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin purification
EP3833382A1 (de) 2018-08-07 2021-06-16 GlaxoSmithKline Biologicals S.A. Verfahren und impfstoffe
WO2020081548A1 (en) * 2018-10-15 2020-04-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Vaccine polypeptide compositions and methods
WO2020109365A1 (en) 2018-11-29 2020-06-04 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
CN110540598B (zh) * 2018-12-20 2021-04-30 湖北工业大学 基于流感嗜血杆菌表面蛋白抗体的流感嗜血杆菌Elisa检测试剂盒及制备方法
JP7640473B2 (ja) 2019-06-05 2025-03-05 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
EP4558170A1 (de) 2022-07-19 2025-05-28 GlaxoSmithKline Biologicals S.A. Kontinuierliches verfahren zur herstellung von impfstoffen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
SU1404512A1 (ru) * 1983-01-27 1988-06-23 Институт биологической физики АН СССР Способ получени динуклеотидов
US5194254A (en) 1986-05-06 1993-03-16 Connaught Laboratories Limited Enhancement of antigen immunogenicity
US5013664A (en) * 1986-05-28 1991-05-07 Brodeur Bernard R Common protein of Haemophilus influenzae type b identified by a monoclonal antibody
US5173294A (en) * 1986-11-18 1992-12-22 Research Foundation Of State University Of New York Dna probe for the identification of haemophilus influenzae
US5192540A (en) * 1988-04-19 1993-03-09 American Cyanamid Company Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
CA2006587C (en) * 1988-12-23 2000-01-18 Robert W. Tolan Membrane proteins and peptides of haemophilus influenzae type b
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
GB8924473D0 (en) * 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
ZA922425B (en) 1991-04-02 1993-02-24 Biotech Australia Pty Ltd Oral delivery systems for microparticles
US5620896A (en) 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization

Also Published As

Publication number Publication date
CA2149319A1 (en) 1994-06-09
CA2149319C (en) 2008-10-07
AU5556594A (en) 1994-06-22
US6013514A (en) 2000-01-11
JP2907552B2 (ja) 1999-06-21
DE69333802D1 (de) 2005-06-09
RU2141528C1 (ru) 1999-11-20
AU683435B2 (en) 1997-11-13
US6264954B1 (en) 2001-07-24
US6083743A (en) 2000-07-04
DE69333802T8 (de) 2006-05-11
GB9224584D0 (en) 1993-01-13
BR9307510A (pt) 1999-06-01
WO1994012641A1 (en) 1994-06-09
EP0668916B1 (de) 2005-05-04
EP0668916A1 (de) 1995-08-30
JPH08502417A (ja) 1996-03-19
DE69333802T2 (de) 2006-01-26

Similar Documents

Publication Publication Date Title
DE69333802D1 (de) Äusseres membranprotein von haemophilus
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
DE68929551D1 (de) Menschliche DNase
DE69428214D1 (de) Transformierender wachstumsfaktor alpha h1
DE69434538D1 (de) Vaskularer endothelialer wachstumsfaktor 2
DE69434839D1 (de) Transferrin-rezeptor gene von haemophilus
ATE113960T1 (de) Proteingewinnung.
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
FR2669338B1 (de)
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
EP0369816A3 (de) Gegen menschliches polymorphes epitheliales Muzin spezifische monoklonale Antikörper
EP0177814A3 (de) Antikörper gegen Peptide und ihre Verwendung zum Nachweis von Onkogene-Produkten
AU3379693A (en) Vaccines and diagnostic assays for haemophilus influenzae
DE69633179D1 (de) Transferrinrezeptorgene
EP0288198A3 (de) Peptidherstellung
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
NZ319639A (en) membrane protein p76 of helicobacter pylori
NO962596L (no) Nytt tumorsupressorgen
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
DK0426314T3 (da) HIV-relaterede peptider

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties